Plasma disposition and fecal elimination of doramectin after oral or intramuscular administration in horses

Veterinary Parasitology

Volumn 170, Issue 1-2, 2010, Pages 112-119

  Perez R ^a   Godoy, C ^b   Palma, C ^a   Munoz L ^a   Arboix, M ^b   Alvinerie, M ^c  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CEMAGREF   (France)

Author keywords

Anthelmintics; Doramectin; Endectocides; Horses; Pharmacokinetics

Indexed keywords

DORAMECTIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DERIVATIZATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; FECES ANALYSIS; FECES LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; FECES; FEMALE; HALF-LIFE; HORSES; INJECTIONS, INTRAMUSCULAR; IVERMECTIN; MALE; PARASITE EGG COUNT;

EQUIDAE;

EID: 77952891941     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2010.01.038     Document Type: Article

References (47)

1. Ali D.N., Hennessy D.R. The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep. J. Vet. Pharmacol. Ther. 1996, 19:89-94.
2. Alvinerie M., Sutra J.F., Badri M., Galtier P. Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection. J. Chromatogr. B 1995, 674:119-124.
3. Alvinerie M., Sutra J.F., Cabezas I., Rubilar L., Pérez R. Enhanced plasma availability of moxidectin in fasted horses. J. Equine Vet. Sci. 2000, 20:575-578.
4. Atta A.H., Abo-Shihada M.N. Comparative pharmacokinetics of doramectin and ivermectin in sheep. J. Vet. Pharmacol. Ther. 2000, 23:49-52.
5. Ballent M., Lifschitz A., Virkel G., Sallowitz J., Lanusse C. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. J. Vet. Pharmacol. Ther. 2007, 30:242-248.
6. Baggot J.D. Disposition and fate of drugs in the body. Veterinary Pharmacology and Therapeutics 1992, 38-71. Iowa State University Press, Ames. sixth ed. H.R. Adams (Ed.).
7. Conder G.A., Baker W.J. Chemistry, pharmacology and safety: doramectin and selamectin. Macrocyclic Lactones in Antiparasitic Therapy. 2002, 30-50. CABI Publishing, Wallingford. J. Vercruysse, R.S. Rew (Eds.).
8. Cook D.F., Dadour I.R., Ali D.N. Effect of diet on the excretion profile of ivermectin in cattle faeces. Int. J. Parasitol. 1996, 26:291-295.
9. Courtney C.H., Robertson E.L. Chemotherapy of parasitic diseases. Veterinary Pharmacology and Therapeutics 1995, Iowa State University Press, Ames. seventh ed. H.R. Adams (Ed.).
10. Cunningham J.G. Textbook of Veterinary Physiology 1992, W.B. Saunders, Philadelphia.
11. Davis J.A., Schwalbach L.M.J. A study to evaluate the field efficacy of ivermectin, fenbendazole and pyrantel pamoate, with preliminary observation on the efficacy of doramectin as anthelmintics in horses. J. S. Afr. Vet. Assoc. 2000, 71:144-147.
12. Escudero E., Carceles C.M., Diaz M.S., Sutra J.F., Galtier P., Alvinerie M. Pharmacokinetics of moxidectin and doramectin in goats. Res. Vet. Sci. 1999, 67:175-179.
13. Farrier D. PK Solutions. Non Compartmental Pharmacokinetics Data Analysis. User Guide 1997, Summit Research Services, Ashland, OH, p. 50.
14. Gokbulut C., Nolan A.M., McKellar Q.A. Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses. Equine Vet. J. 2001, 33:494-498.
15. Gokbulut C., Boyacioglu M., Karademir U. Plasma pharmacokinetics and faecal excretion of ivermectin and doramectin following oral administration in donkeys. Res. Vet. Sci. 2005, 79:233-238.
16. Goudie A.C., Evans N.A., Gration K.A.F., Bishop B.F., Gibson S.P., Holdom K.S., Kaye B., Wicks S.R., Lewis D., Weatherley A.J., Bruce C.I., Herbert A., Seymour D.J. Doramectin a potent novel endectocide. Vet. Parasitol. 1993, 49:5-15.
17. Hennessy D.R., Steel J.W., Prichard R.K. Biliary secretion and enterohepatic recycling of fenbendazole metabolites in sheep. J. Vet. Pharmacol. Ther. 1993, 16:132-140.
18. Hennessy D.R., Page S.W., Gottschall D. The behaviour of doramectin in the gastrointestinal tract, its excretion in bile and pharmacokinetic disposition in the peripheral circulation after oral and intravenous administration to sheep. J. Vet. Pharmacol. Ther. 2000, 23:203-213.
19. Herd R.P., Stinner B.R., Purrington F.F. Dung dispersal and grazing area following treatment of horses with a single dose of ivermectin. Vet. Parasitol. 1993, 48:229-240.
20. Herd R. Endectocidal drugs: ecological risks and counter-measures. Int. J. Parasitol. 1995, 25:875-885.
21. Lanusse C., Prichard R.K. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Vet. Parasitol. 1993, 49:123-158.
22. Lanusse C., Lifschitz A., Virkel G., Alvarez L., Sánchez S., Sutra J.F., Galtier P., Alvinerie M. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J. Vet. Pharmacol. Ther. 1997, 20:91-99.
23. Lecureur V., Courtois A., Payen L., Verhnet L., Guillouzo A., Fardel O. Expression and regulation of hepatic drug and bile acid transporters. Toxicology 2000, 153:203-209.
24. Lifschitz A., Virkel G., Sallowitz J., Sutra J.F., Galtier P., Alvinerie M., Lanusse C. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Vet. Parasitol. 2000, 87:327-338.
25. Lifschitz A., Ballent M., Virkel G., Sallowitz J., Lanusse C. Modulation of P-glycoprotein intestinal activity enhances ivermectin absorption in sheep. J. Vet. Pharmacol. Ther. 2006, 29(Suppl. 1):249-250.
26. Luz-Pereira A.B., Cavichiolli J.H., Guimaraes J.S., Batiston A., Gusmao R.A.M. Eficácia a campo do mebendazole, oxibendazole, pamoato de pirantel e doramectin contra pequeños estrongilídeos (cyathostominae) de eqüinos. Rev. Bras. Parasitol. Vet. 1994, 3:93-97.
27. Marriner S.E., McKinnon Y., Bogan J.A. The pharmacokinetics of ivermectin after oral and subcutaneous administration to sheep and horses. J. Vet. Pharmacol. Ther. 1987, 10:175-179.
28. Martínez M., Amidon G., Clarke L., Warren-Jones W., Mitra A., Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations. Adv. Drug Deliv. Res. 2002, 54:825-850.
29. Martinez M., Modric S., Sharkey M., Troutman L., Walker L., Mealey K. The pharmacogenomics of P-glycoprotein and its role in veterinary medicine. J. Vet. Pharmacol. Ther. 2008, 32:285-300.
30. McKellar Q.A., Benchaoui H.A. Avermectins and milbemycins. J. Vet. Pharmacol. Ther. 1996, 19:331-351.
31. McKellar Q.A. Ecotoxicology and residues of anthelmintic compounds. Vet. Parasitol. 1997, 72:413-435.
32. Nowakowski M., Lynch M., Smith D., Logan N., Mouzin D., Lukaszewicz J., Ryan N., Hunter R., Jones R. Pharmacokinetics and bioequivalence of parenterally administered doramectin in cattle. J. Vet. Pharmacol. Ther. 1995, 18:290-298.
33. ®) in horses. J. Vet. Pharmacol. Ther. 1999, 22:174-180.
34. Perez R., Cabezas I., Sutra J.F., Galtier P., Alvinerie M. Faecal excretion profile of moxidectin and ivermectin after oral administration in horses. Vet. J. 2001, 161:85-92.
35. Pérez R., Godoy C., Palma C., Cabezas I., Rubilar L., Muñoz L., Arboix M., Alvinerie M. The effect of the administration route on plasma profile and efficacy of ivermectin in horses. J. Vet. Med. 2003, 50:297-302.
36. Prichard R.K., Gascon L.H., Lanusse C.E. Selection of route of administration in the treatment of gastrointestinal roundworm infection. Acta Vet. Scand. Suppl. 1991, 87:65-74.
37. Riviere J.E. Comparative Pharmacokinetics: Principles, Techniques and Applications 1999, Iowa State University Press, Ames, Iowa, pp. 148-167.
38. Sallovitz J.M., Lifschitz A., Imperiale F., Virkel G., Larghi J., Lanusse C. Doramectin concentration profiles in the gastrointestinal tract of topically treated calves: influence of animal licking restriction. Vet. Parasitol. 2005, 133:61-70.
39. Shoop W.L., Mrozik H., Fisher M.H. Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol. 1995, 59:139-156.
40. Sklavounos C., Dmers N., Lukaszewicks, Nowakowski M. Photoisomerization of aromatic doramectin derivatives. J. Agric. Food Chem. 1994, 42:1228-1231.
41. Strong L. Avermectins: a review of their impact on insects of cattle dung. Bull. Entomol. Res. 1992, 82:265-267.
42. Suarez V.H., Lifschitz A.L., Sallovitz J.M., Lanusse C.E. Effects of ivermectin and doramectin faecal residues on the invertebrate colonization of cattle dung. J. Appl. Enthomol. 2003, 127:481-488.
43. Taylor S.M., Mallon T.R., Blanchflower W.J., Kennedy D.G., Green W.P. Effects of diet on plasma concentrations of oral anthelmintics for cattle and sheep. Vet. Rec. 1992, 130:264-268.
44. Toutain P.L., Upson D.W., Terhune T.N., McKenzie N.E. Comparative pharmacokinetics of doramectin and ivermectin in cattle. Vet. Parasitol. 1997, 72:3-8.
45. Tydén E., Tallkvist J., Tjalve H., Larsson P. P-glycoprotein in intestines, liver, kidneys and lymphocytes in horses. J. Vet. Pharmacol. Ther. 2009, 32:167-176.
46. Wall R., Strong L. Environmental consequences of treating cattle with antiparasitic drug ivermectin. Nature 1987, 324:418-420.
47. Wicks S.R., Kaye B., Weatherley A.J., Lewis D., Davidson E., Gibson S.P., Smith D.G. Effect of formulation on the pharmacokinetics and efficacy of doramectin. Vet. Parasitol. 1993, 49:17-26.